WTAP activates the proliferation of RCC cells by regulating the stability of CDK2 mRNA, leading to the occurrence and development of RCC; patients with RCC and overexpression of WTAP have a dismal prognosis.112. This evidence concerns the gene CDK2 and renal cell carcinoma.